Activation of the noradrenaline transporter gene using the radiation-inducible WAF1-1 promoter sensitizes tumour cells to [I-131] MIBG targeted radiotherapy
McCluskey, A. G. and Mairs, R. J. and Robson, T. and Hirst, D. G. and Boyd, M. (2012) Activation of the noradrenaline transporter gene using the radiation-inducible WAF1-1 promoter sensitizes tumour cells to [I-131] MIBG targeted radiotherapy. Mutagenesis, 27 (1). p. 131. 82. ISSN 0267-8357 (https://doi.org/10.1093/mutage/ger068)
Full text not available in this repository.Request a copyAbstract
Radiotherapy given in combination with gene transfer is a promising approach for the treatment of cancer. However, progress in this field depends upon achieving the selective expression of therapeutic transgenes in tumours. Therefore, radiation-inducible gene promoters have attracted interest because they may enable temporal and spatial gene activation.
ORCID iDs
McCluskey, A. G.

-
-
Item type: Article ID code: 40162 Dates: DateEvent2012PublishedKeywords: noradrenaline transporter, radiotherapy, Pharmacy and materia medica, Genetics, Genetics(clinical), Health, Toxicology and Mutagenesis, Toxicology, SDG 3 - Good Health and Well-being Subjects: Medicine > Pharmacy and materia medica Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Technology and Innovation Centre > Advanced Science and Technology
Technology and Innovation Centre > BionanotechnologyDepositing user: Pure Administrator Date deposited: 22 Jun 2012 08:29 Last modified: 18 Jan 2023 09:23 URI: https://strathprints.strath.ac.uk/id/eprint/40162
CORE (COnnecting REpositories)